Pfizer

Executive Summary

John Niblack, PhD, to exec VP-R&D upon the retirement of Barry Bloom, PhD, Sept. 1. George Milne, PhD, will succeed Niblack as president of Pfizer Central Research, and Craig Saxton, MD, will become exec VP of Central Research. Milne and Saxton have both been elected corporate VPs. Bloom joined Pfizer in 1952 and was named Central Research president in 1971 and corporate exec VP in 1992. Pfizer Chairman William Steere praised Bloom's career at Pfizer, saying he "elevated the status of Pfizer research and clearly focused its efforts so that today it stands as the envy of the industry".